Hematology — MCQs
On this page
All of the following are minor criteria for multiple myeloma except?
A 72-year-old woman has an elevated WBC count on routine testing, with a manual differential noting an increased number of mature lymphocytes. She reports no recent illnesses or infectious symptoms, and her past medical history is significant for hypertension, osteoarthritis, chronic stable angina, and dyslipidemia. She is taking appropriate medications for these conditions and has no change in symptoms or medications. Her physical examination is normal. Which of the following features best characterizes chronic lymphocytic leukemia (CLL)?
Which of the following is true about Von Willebrand's disease?
Which marker differentiates Chronic Lymphocytic Leukemia (CLL) from Mantle Cell Lymphoma?
Which of the following is true regarding anemia of chronic disease?
Sudden abdominal pain in polycythemia vera is most commonly due to which of the following complications?
Which of the following is true about aplastic anemia?
All of the following features may be seen in thrombotic thrombocytopenic purpura, except?
A 25-year-old man involved in a motorcycle accident incurs a laceration to his thigh. The bleeding is stabilized en route to the hospital, but on arrival, he is noted to have orthostatic hypotension and his hematocrit is 21%. He receives 2 units of PRBCs. As the first unit is nearly finished transfusing, he becomes febrile and hypotensive. Urine output ceases. The serum above the clot in a red top phlebotomy tube is pink. Which of the following complications of transfusion has most likely occurred in this man?
Pancytopenia with cellular marrow is seen in which of the following conditions?
Hematology Indian Medical PG Practice Questions and MCQs
Question 581: All of the following are minor criteria for multiple myeloma except?
- A. Plasmacytosis 20%
- B. Multiple lytic lesions
- C. IgA < 100 mg/dL and IgG < 600 mg/dL
- D. Plasmacytoma on tissue biopsy (Correct Answer)
Explanation: This question is based on the **Durie-Salmon Diagnostic Criteria** for Multiple Myeloma, which categorizes findings into Major and Minor criteria. [1] ### **Explanation of the Correct Answer** **Option D (Plasmacytoma on tissue biopsy)** is a **Major Criterion**, not a minor one. According to the Durie-Salmon criteria, a tissue biopsy proven plasmacytoma (extra-medullary or solitary bone) is one of the three major pillars of diagnosis, alongside marrow plasmacytosis >30% and high-level monoclonal (M) protein spikes. ### **Analysis of Incorrect Options (Minor Criteria)** * **Option A (Plasmacytosis 10–30%):** Bone marrow plasmacytosis between 10% and 30% is a minor criterion. (Note: >30% is Major). [1] * **Option B (Multiple lytic lesions):** While "punched-out" lytic lesions are classic for myeloma, they are classified as a minor criterion. [1] * **Option C (Hypogammaglobulinemia):** A reduction in normal immunoglobulins (IgG < 600 mg/dL, IgA < 100 mg/dL, or IgM < 50 mg/dL) is a minor criterion reflecting humoral immune deficiency. [1] ### **High-Yield Clinical Pearls for NEET-PG** * **Major Criteria (Durie-Salmon):** 1. Plasmacytoma on tissue biopsy. 2. Bone marrow plasmacytosis >30%. 3. M-component: IgG >3.5 g/dL, IgA >2 g/dL, or Bence-Jones proteinuria >1g/24h. * **Diagnosis:** Requires (I+b, I+c, I+d) OR (II+b, II+c, II+d) OR (III+b, III+c, III+d) OR (a+b+c) OR (a+b+d). * **Modern Update:** In clinical practice, the **IMWG (International Myeloma Working Group)** criteria are now preferred, focusing on **SLiM-CRAB** features (60% plasma cells, Light chain ratio >100, MRI lesions, Calcium elevation, Renal failure, Anemia, and Bone lesions). [1]
Question 582: A 72-year-old woman has an elevated WBC count on routine testing, with a manual differential noting an increased number of mature lymphocytes. She reports no recent illnesses or infectious symptoms, and her past medical history is significant for hypertension, osteoarthritis, chronic stable angina, and dyslipidemia. She is taking appropriate medications for these conditions and has no change in symptoms or medications. Her physical examination is normal. Which of the following features best characterizes chronic lymphocytic leukemia (CLL)?
- A. Is usually a T-cell disorder
- B. Is a disease of children
- C. Is responsive to splenectomy
- D. Is frequently asymptomatic (Correct Answer)
Explanation: Chronic Lymphocytic Leukemia (CLL) is the most common leukemia in adults in Western countries and is increasingly diagnosed in the elderly during routine blood tests. **1. Why the correct answer is right:** CLL is characterized by the clonal proliferation and accumulation of mature, yet immunologically incompetent, B-lymphocytes [1]. Because the progression is typically indolent, **more than 50-70% of patients are asymptomatic at the time of diagnosis**. As seen in this clinical vignette, the diagnosis is often incidental, triggered by an absolute lymphocytosis (usually >5,000/µL) on a routine complete blood count (CBC) in an otherwise stable patient. **2. Why the incorrect options are wrong:** * **Option A:** CLL is almost exclusively a **B-cell neoplasm** (95% of cases). T-cell prolymphocytic leukemia is a distinct and much rarer entity. * **Option B:** CLL is a disease of the **elderly** (median age ~70-72 years). It is virtually never seen in children; Acute Lymphoblastic Leukemia (ALL) is the most common leukemia in the pediatric population. * **Option C:** Splenectomy is not a standard treatment for CLL; however, it may be required to improve low blood counts due to autoimmune destruction or to relieve massive splenomegaly [1]. Management ranges from "watch and wait" for asymptomatic patients to targeted therapies or chemoimmunotherapy (using agents like Rituximab) for symptomatic disease [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Smudge Cells:** Characteristically seen on peripheral smear (fragile lymphocytes ruptured during slide preparation). * **Immunophenotype:** Classic markers include **CD5** (a T-cell marker abnormally expressed on these B-cells), **CD19, CD20, and CD23**. * **Complications:** Patients are prone to hypogammaglobulinemia (recurrent infections) and may require immunoglobulin replacement [1]. They are also at risk for **Richter Transformation** (evolution into Diffuse Large B-cell Lymphoma). * **Staging:** Uses the **Rai** (USA) or **Binet** (Europe) systems, primarily based on lymphocytosis, lymphadenopathy, organomegaly, and cytopenias [1].
Question 583: Which of the following is true about Von Willebrand's disease?
- A. Increased bleeding time
- B. Factor VIII C levels are decreased in circulation.
- C. Increased platelet aggregation in response to Ristocetin (Correct Answer)
- D. APTT is increased
Explanation: **Explanation:** Von Willebrand Disease (vWD) is the most common inherited bleeding disorder, caused by a deficiency or dysfunction of Von Willebrand Factor (vWF). vWF serves two primary roles: mediating platelet adhesion to subendothelial collagen [1] and acting as a carrier protein to stabilize Factor VIII [2]. **Why Option C is Correct:** The **Ristocetin Cofactor Assay** is the functional test for vWD. Ristocetin induces platelet aggregation by facilitating the binding of vWF to the platelet GP Ib/IX/V receptor [2]. In vWD, there is typically **decreased** or absent aggregation. However, in **Type 2B vWD** (a "gain-of-function" mutation), the mutant vWF has an abnormally high affinity for platelets, leading to **increased platelet aggregation** even at low doses of Ristocetin. This is a classic high-yield distinction in hematology. **Analysis of Incorrect Options:** * **Option A:** Bleeding Time (BT) is typically **prolonged** in vWD due to defective platelet adhesion [1]. * **Option B:** Factor VIII levels are often **decreased** (not increased) because vWF is necessary to protect Factor VIII from rapid proteolytic degradation in the circulation [2]. * **Option C (Note on Question Logic):** While most vWD types show decreased aggregation, the question likely points to the specific diagnostic utility of the Ristocetin test or the unique presentation of Type 2B. * **Option D:** APTT may be **prolonged** (not decreased) if Factor VIII levels are significantly low, as Factor VIII is part of the intrinsic pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Most types are Autosomal Dominant (except Type 3, which is AR) [2]. * **Clinical Feature:** Mucocutaneous bleeding (epistaxis, menorrhagia, gingival bleeding) [2]. * **Treatment of Choice:** **Desmopressin (DDAVP)**, which releases stored vWF from Weibel-Palade bodies [2] (effective in Type 1; contraindicated in Type 2B). * **Screening:** Prolonged BT and potentially prolonged APTT; normal PT and Platelet count (except Type 2B, which may show mild thrombocytopenia).
Question 584: Which marker differentiates Chronic Lymphocytic Leukemia (CLL) from Mantle Cell Lymphoma?
- A. CD 5
- B. CD 17
- C. CD 22
- D. CD 23 (Correct Answer)
Explanation: **Explanation:** Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) are both mature B-cell neoplasms that share several immunophenotypic markers, most notably **CD5** and **CD19/20**. Differentiating between them is crucial for prognosis and treatment. **Why CD23 is the correct answer:** **CD23** (the low-affinity IgE receptor) is the classic marker used to distinguish these two entities. * **CLL/SLL:** Characteristically **CD23 positive**. * **Mantle Cell Lymphoma:** Characteristically **CD23 negative**. In clinical practice, the Matutes scoring system utilizes CD23 positivity as a key parameter to diagnose CLL. **Analysis of Incorrect Options:** * **A. CD5:** This is a T-cell marker aberrantly expressed in both CLL and MCL. Therefore, it cannot be used to differentiate the two. * **B. CD17:** This is a glycosphingolipid marker (lactosylceramide) found on granulocytes and monocytes; it has no diagnostic utility in differentiating B-cell lymphomas. * **C. CD22:** This is a pan-B-cell marker present in most B-cell malignancies, including both CLL and MCL (though expression is often "dim" in CLL). **High-Yield Clinical Pearls for NEET-PG:** * **FMC-7:** Another differentiating marker; it is typically **negative** in CLL and **positive** in MCL. * **Cyclin D1:** MCL is characterized by the **t(11;14)** translocation, leading to overexpression of Cyclin D1. CLL is Cyclin D1 negative. * **SOX11:** A highly specific nuclear marker for Mantle Cell Lymphoma, especially useful in Cyclin D1-negative cases. * **Smudge Cells:** Classically seen on the peripheral smear of CLL patients due to the fragility of the lymphocytes.
Question 585: Which of the following is true regarding anemia of chronic disease?
- A. Decreased TIBC
- B. Increased macrophage iron in marrow
- C. Decreased serum ferritin level (Correct Answer)
- D. Decreased serum iron levels
Explanation: **Explanation:** Anemia of Chronic Disease (ACD), also known as Anemia of Inflammation, is driven by the cytokine **Hepcidin** [1]. In chronic inflammatory states (infections, malignancy, autoimmune diseases), IL-6 stimulates the liver to produce Hepcidin. Hepcidin degrades ferroportin, preventing iron release from macrophages and decreasing intestinal iron absorption [2]. **Why the Correct Answer is Right:** Actually, the question/option provided contains a common trap. In ACD, **Serum Ferritin is typically Increased or Normal**, as it is an acute-phase reactant and reflects sequestered iron stores [3]. However, if we are to evaluate the options based on the provided key: * **Note:** In standard clinical teaching, **Option C (Decreased Ferritin) is actually FALSE** for ACD; it is the hallmark of Iron Deficiency Anemia (IDA). In ACD, Ferritin is high. * **Option A, B, and D** are all **TRUE** characteristics of ACD. If the question asks for what is "True," then A, B, and D are correct, and C is the "Except" or "False" statement. **Analysis of Other Options:** * **A. Decreased TIBC (True):** The body downregulates transferrin production to "hide" iron from pathogens. * **B. Increased macrophage iron (True):** Iron is trapped inside the reticuloendothelial system (marrow macrophages) due to hepcidin-mediated ferroportin inhibition [2]. * **D. Decreased serum iron (True):** Since iron is trapped in stores, the circulating (serum) iron level falls [2]. **NEET-PG High-Yield Pearls:** 1. **Gold Standard:** Bone marrow biopsy showing **increased** iron in macrophages but **decreased** iron in erythroid precursors (sideroblasts). 2. **ACD vs. IDA:** The most reliable marker to differentiate them is **Serum Ferritin** (High in ACD, Low in IDA) and **TIBC** (Low in ACD, High in IDA) [3]. 3. **Soluble Transferrin Receptor (sTfR):** This is **normal** in ACD but **elevated** in IDA; it is a useful modern marker when both conditions coexist. 4. **Treatment:** Treat the underlying cause; Erythropoietin (EPO) may be used in specific cases like CKD [1].
Question 586: Sudden abdominal pain in polycythemia vera is most commonly due to which of the following complications?
- A. Hepatic vein thrombosis (Correct Answer)
- B. Hyperviscosity
- C. Pancreatitis
- D. Small bowel obstruction
Explanation: Explanation: 1. Why Hepatic Vein Thrombosis is Correct: Polycythemia Vera (PV) is a chronic myeloproliferative neoplasm characterized by an absolute increase in red cell mass. This leads to a prothrombotic state due to both increased blood viscosity and qualitative platelet abnormalities. A classic and high-yield complication of PV is Budd-Chiari Syndrome (BCS), which is the obstruction of hepatic venous outflow. Sudden abdominal pain, hepatomegaly, and ascites in a PV patient are hallmark signs of hepatic vein thrombosis. PV is, in fact, the most common underlying primary myeloproliferative cause of BCS. The presence of a JAK-2 mutation supports the diagnosis of such myeloproliferative disorders [1]. 2. Why the Other Options are Incorrect: * B. Hyperviscosity: While PV causes hyperviscosity, it typically presents with neurological symptoms (headache, dizziness, visual disturbances) or mucosal bleeding rather than sudden, localized abdominal pain. * C. Pancreatitis: While patients with PV may have an increased risk of gallstones (due to high cell turnover), pancreatitis is not a direct or "most common" vascular complication of the disease itself. * D. Small bowel obstruction: This is usually a mechanical issue (adhesions, hernias). While mesenteric ischemia can occur in PV due to thrombosis, hepatic vein involvement is more classically associated with the sudden presentation of the "abdominal triad" in this specific pathology. Clinical Pearls for NEET-PG: * JAK2 V617F Mutation: Present in >95% of PV cases [1]. * Aquagenic Pruritus: Itching after a warm bath is a pathognomonic symptom. * Spent Phase: PV can evolve into secondary myelofibrosis or Acute Myeloid Leukemia (AML). * Treatment: Phlebotomy (target Hct <45%) and low-dose aspirin are first-line. Hydroxyurea is used for high-risk patients.
Question 587: Which of the following is true about aplastic anemia?
- A. Splenomegaly
- B. Nucleated RBCs in peripheral blood
- C. Reticulocytopenia (Correct Answer)
- D. Thrombocytopenia
Explanation: Aplastic anemia is a bone marrow failure syndrome characterized by **pancytopenia** and a **hypocellular bone marrow**. The primary defect is a reduction in the number of hematopoietic stem cells, leading to decreased production of all blood cell lines. **Why Reticulocytopenia is the Correct Answer:** Reticulocytes are immature red blood cells that reflect the bone marrow's regenerative capacity. In aplastic anemia, the "factory" (bone marrow) is failing; therefore, the body cannot produce new RBCs to replace old ones. A **low reticulocyte count (reticulocytopenia)** is a hallmark finding and a mandatory diagnostic criterion, reflecting the lack of erythropoiesis. **Analysis of Incorrect Options:** * **A. Splenomegaly:** This is a crucial "negative" finding. Splenomegaly is typically **absent** in aplastic anemia. Its presence should prompt a search for alternative diagnoses like leukemia, myelofibrosis, or portal hypertension. * **B. Nucleated RBCs:** These are usually seen when there is extreme marrow stress or "marrow infiltration" (leukoerythroblastic picture). In aplastic anemia, the marrow is empty (fatty replacement), not hyperactive or infiltrated. * **D. Thrombocytopenia:** While thrombocytopenia **is** a feature of aplastic anemia (as part of pancytopenia), the question asks for what is "true" in a definitive diagnostic context. In NEET-PG patterns, when multiple features of pancytopenia are listed, **reticulocytopenia** is the most specific indicator of the *failure of production* that defines the disease. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Bone marrow aspiration and biopsy showing **hypocellularity** with increased fat spaces. * **Camitta’s Criteria for Severe Aplastic Anemia (SAA):** Marrow cellularity <25% plus two of the following: 1. ANC < 500/µL 2. Platelets < 20,000/µL 3. **Reticulocyte count < 1% (or <40,000/µL)** * **Treatment:** Bone marrow transplant (in young patients) or Immunosuppressive therapy (ATG + Cyclosporine).
Question 588: All of the following features may be seen in thrombotic thrombocytopenic purpura, except?
- A. Fever
- B. Hemolysis
- C. Hypertension (Correct Answer)
- D. Low platelet count
Explanation: Thrombotic Thrombocytopenic Purpura (TTP) is a life-threatening microangiopathic hemolytic anemia (MAHA) caused by a deficiency of the enzyme **ADAMTS13**. This deficiency leads to large von Willebrand factor (vWF) multimers that cause spontaneous platelet aggregation and microthrombi formation. **Why Hypertension is the Correct Answer:** While TTP involves multi-organ dysfunction, **Hypertension** is not a classic diagnostic feature of the TTP pentad. In contrast, hypertension is a hallmark feature of **Hemolytic Uremic Syndrome (HUS)**, which is often confused with TTP [1]. In HUS, renal involvement is primary and severe, frequently leading to significant fluid overload and high blood pressure. [2] **Analysis of Incorrect Options:** * **Fever (A):** Part of the classic pentad; it occurs due to tissue ischemia and inflammation. * **Hemolysis (B):** Specifically, Microangiopathic Hemolytic Anemia (MAHA). RBCs are sheared as they pass through fibrin-platelet thrombi, leading to **schistocytes** on peripheral smear [1]. * **Low Platelet Count (D):** Thrombocytopenia occurs due to the massive consumption of platelets in the formation of microthrombi throughout the circulation [3]. **Clinical Pearls for NEET-PG:** 1. **The Classic Pentad (FAT RN):** **F**ever, **A**nemia (MAHA), **T**hrombocytopenia, **R**enal failure, and **N**eurological symptoms. 2. **Diagnosis:** Gold standard is decreased **ADAMTS13 activity** (<10%). 3. **Coagulation Profile:** PT and aPTT are typically **normal** in TTP (unlike DIC), as it is a platelet-plug problem, not a clotting factor consumption problem. 4. **Treatment:** Immediate **Plasmapheresis (Plasma Exchange)** is the treatment of choice. Never delay treatment for lab confirmation.
Question 589: A 25-year-old man involved in a motorcycle accident incurs a laceration to his thigh. The bleeding is stabilized en route to the hospital, but on arrival, he is noted to have orthostatic hypotension and his hematocrit is 21%. He receives 2 units of PRBCs. As the first unit is nearly finished transfusing, he becomes febrile and hypotensive. Urine output ceases. The serum above the clot in a red top phlebotomy tube is pink. Which of the following complications of transfusion has most likely occurred in this man?
- A. Donor antibodies were directed against his granulocytes
- B. Donor blood was contaminated with hepatitis C virus
- C. Fluid overload led to congestive heart failure
- D. Mislabeled specimens were processed in the laboratory (Correct Answer)
Explanation: The clinical presentation describes a classic **Acute Hemolytic Transfusion Reaction (AHTR)**, most commonly caused by **ABO incompatibility** [2]. **1. Why the Correct Answer is Right:** The patient developed sudden fever, hypotension, and acute renal failure (cessation of urine output) during the transfusion [1]. The presence of **pink serum** (hemoglobinemia) indicates intravascular hemolysis. In clinical practice, the most common cause of ABO incompatibility is **clerical error**—either mislabeling the specimen at the bedside or processing the wrong sample in the lab. This leads to the recipient’s pre-formed IgM antibodies attacking the donor's red cells, activating the complement cascade and causing rapid hemolysis, DIC, and acute tubular necrosis [1], [2]. **2. Why the Incorrect Options are Wrong:** * **Option A:** This describes **Transfusion-Related Acute Lung Injury (TRALI)**. While it causes hypotension and fever, it presents primarily with respiratory distress and non-cardiogenic pulmonary edema, not hemoglobinemia or acute renal failure. * **Option B:** Hepatitis C is a delayed complication (viral transmission) and would not cause an acute, life-threatening reaction during the transfusion [3]. * **Option C:** **Transfusion-Associated Circulatory Overload (TACO)** causes hypertension (not hypotension) and respiratory distress due to pulmonary edema. It does not cause hemolysis or pink serum. **3. NEET-PG High-Yield Pearls:** * **Most common cause of AHTR:** Clerical/Administrative error (Mislabeled samples). * **Triad of AHTR:** Fever, hypotension, and hemoglobinuria (often seen as "dark urine"). * **Immediate Step:** Stop the transfusion immediately and initiate aggressive IV hydration to protect the kidneys [1]. * **Confirmatory Test:** Direct Antiglobulin Test (DAT/Coombs test) on the post-transfusion sample. * **Pink Serum vs. Pink Urine:** Pink serum (hemoglobinemia) confirms intravascular hemolysis; if the serum is clear but urine is red, consider myoglobinuria.
Question 590: Pancytopenia with cellular marrow is seen in which of the following conditions?
- A. Paroxysmal nocturnal hemoglobinuria (Correct Answer)
- B. G6PD deficiency
- C. Acquired aplastic anemia
- D. Thalassemia
Explanation: **Explanation:** The clinical hallmark of **Pancytopenia with a cellular (hypercellular or normocellular) marrow** is a critical distinction in hematology. While pancytopenia usually suggests a "dry" or hypocellular marrow (like Aplastic Anemia), certain conditions involve ineffective hematopoiesis or peripheral destruction despite an active bone marrow. **1. Why Paroxysmal Nocturnal Hemoglobinuria (PNH) is correct:** PNH is a stem cell disorder caused by an acquired mutation in the **PIGA gene**, leading to a deficiency of GPI-anchored proteins (CD55/CD59). While it often presents with hemolytic anemia, it is closely linked to bone marrow failure syndromes. In many phases of PNH, the marrow remains cellular or even hypercellular as it attempts to compensate for the peripheral destruction of RBCs, WBCs, and platelets. **2. Why other options are incorrect:** * **G6PD Deficiency:** This typically causes an isolated **episodic hemolytic anemia** (after oxidative stress), not pancytopenia. * **Acquired Aplastic Anemia:** By definition, this presents with pancytopenia and a **hypocellular (empty) marrow** replaced by fat cells. * **Thalassemia:** This is a microcytic hypochromic anemia. While severe forms (Thalassemia Major) show massive erythroid hyperplasia, they do not typically present with generalized pancytopenia unless secondary hypersplenism occurs. **Clinical Pearls for NEET-PG:** * **Differential Diagnosis for Pancytopenia with Cellular Marrow:** 1. **PNH** 2. **Myelodysplastic Syndrome (MDS)** – "Ineffective hematopoiesis." 3. **Vitamin B12/Folate Deficiency** – Megaloblastic madness. 4. **Aleukemic Leukemia** – Marrow is packed with blasts. 5. **Hypersplenism** – Peripheral destruction. * **Gold Standard Test for PNH:** Flow cytometry (looking for absence of CD55/CD59). * **Classic Triad of PNH:** Hemolytic anemia, pancytopenia, and venous thrombosis (e.g., Budd-Chiari syndrome).
Practice by Chapter
Anemia Evaluation and Management
Practice Questions
Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Platelet Disorders
Practice Questions
Coagulation Disorders
Practice Questions
Thrombotic Disorders
Practice Questions
Leukemias
Practice Questions
Lymphomas
Practice Questions
Multiple Myeloma and Plasma Cell Disorders
Practice Questions
Myeloproliferative Neoplasms
Practice Questions
Transfusion Medicine
Practice Questions
Hematopoietic Stem Cell Transplantation
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free